No Picture
Trading Ideas

Gold gains on U.S.-China trade friction, global stimulus

U.S. gold futures gained 0.3% to $1,739.80. Despite the news on a potential coronavirus vaccine lighting a fire under the equity markets, gold will remain very well bid due to the “ridiculously huge” Federal Reserve balance sheet, said Stephen Innes, chief market strategist at financial services firm AxiCorp. On Monday, the metal hit its highest since October 2012 before retreating to close lower, as stocks and oil surged after drugmaker Moderna said its COVID-19 experimental vaccine showed promising results in an early-stage trial. …read more […]

No Picture
Trading Ideas

Moderna Prices $1.3B Equity Offering at $76/Share

Moderna (MRNA) has now priced an underwritten public offering of 17,600,000 shares at a public offering price of $76 per share, before underwriting discounts and commissions.In addition, MRNA has granted the underwriters a 30-day option to purchase up to an additional 2,640,000 shares of common stock at the public offering price.Gross proceeds from the offering will be approximately $1.34 billion, says Moderna.The offering is expected to close on or about May 21, 2020, subject to customary closing conditions.Shares in Moderna pulled back 3% in Monday’s after-hours trading, following a 20% rally during the day after the biotech reported “positive” interim …read more […]

No Picture
Business News

White House panel: Build new tech infrastructure for future jobs

A White House advisory panel on Tuesday will call for the government and private industry to work together to build new technological infrastructure to support future jobs and provide the underpinnings critical to a solid economic recovery from the coronavirus pandemic, an official briefed on the plans said.

…read more […]

No Picture
Trading Ideas

Moderna Stock Offering Is to Price at $76 Per Share

(Bloomberg) — Moderna Inc. plans to raise as much as $1.3 billion through a sale of shares to fund manufacturing of a coronavirus vaccine seen as one of the frontrunners in the race for immunization against the widening pandemic. The U.S. biotechnology firm will sell 17.6 million shares priced at $76 a piece, according to a statement Tuesday. The price represents a 5% discount to Monday’s closing price.Morgan Stanley is the sole book-running manager for the offering that allows underwriters to buy an additional 2.64 million shares, the statement said. Bloomberg reported the share sale plan earlier.Shares jumped 20% on …read more […]